The current ARTH market cap is 9.3M. The company's latest EPS is USD -1.4725 and P/E is -1.33.
Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 12k | 16k | 76k |
Operating Income | -6.37M | -5.37M | -6.39M | -5.71M | -5.04M |
Net Income | -4.55M | -4.69M | -6.25M | -5.28M | -6.98M |
Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 2.9M | 2.15M | 3.68M | 2.6M | 1.96M |
Total Liabilities | 3.71M | 3.65M | 4.7M | 6.8M | 9.47M |
Total Equity | -807k | -1.5M | -1.03M | -4.19M | -7.51M |
Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -5.27M | -5.05M | -5.96M | -4.46M | -3.37M |
Investing | N/A | -2k | -3k | N/A | -5k |
Financing | 2.78M | 3.83M | 7.27M | 2.94M | 2.86M |
Market Cap | 9.3M |
Price to Earnings Ratio | -1.33 |
Price to Sales Ratio | 122.5 |
Price to Cash Ratio | 41.7 |
Price to Book Ratio | -1.24 |
Dividend Yield | - |
Shares Outstanding | 4.74M |
Average Volume (1 week) | 1.5k |
Average Volume (1 Month) | 2.33k |
52 Week Change | -37.78% |
52 Week High | 18.00 |
52 Week Low | 0.39 |
Spread (Intraday) | 0.11 (5.61%) |
Company Name | Arch Therapeutics Inc (QB) |
Address |
769 basque way carson city, nevada 89706 |
Website | https://www.archtherapeutics.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.